Can a positive attitude help beat breast cancer recurrence? new study tests online training

NCT ID NCT06388304

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested an online program called THRIVE, based on Positive Affect Training, to help breast cancer survivors feel better about taking their anti-hormonal medication. The goal was to see if the program was acceptable and feasible for women who struggle with side effects or negative feelings about their daily pills. Thirty-nine survivors of hormone receptor-positive breast cancer participated after finishing primary treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

THRIVE Online Positive Affect Training (PAT) program

What this could lead to

If it works, this could offer a simple online tool to help breast cancer survivors stick with their anti-hormonal medication and feel less distressed about side effects.

What could go wrong

This is a very small pilot study with only 39 participants and no control group, so results may not apply widely. The program may not improve adherence or emotional well-being in larger, more diverse groups.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm ductal breast carcinoma in situ

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Colorado Boulder

    Boulder, Colorado, 80309, United States